← Browse by Condition
Medical Condition

radioiodine refractory differentiated thyroid cancer

Total Trials
1
Recruiting Now
1
Trial Phases
EARLY_Phase 1
NCT06898437 EARLY_Phase 1
Recruiting

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

Enrollment
20 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →